- 1Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
- 2Department of Pain Treatment, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China
- 3Center for New Drug Safety Evaluation and Research, China Pharmaceutical University, Nanjing, Jiangsu, China
This article has been retracted. Please follow the link to the full retraction notice for details.
Citation: Yu J, Meng F, Sui W, Yu J and Shen J (2024) Concomitant use of renin-angiotensin system inhibitors augments the efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis. Front. Pharmacol. 15:1378577. doi: 10.3389/fphar.2024.1378577
Received: 29 January 2024; Accepted: 17 May 2024;
Published: 04 June 2024.; Retracted: 07 November 2025.
Edited by:
Rakesh K. Jain, Massachusetts General Hospital and Harvard Medical School, United StatesReviewed by:
Benjamin Wolf, Leipzig University, GermanyNathan Andrew Holland, Texas Tech University Health Sciences Center El Paso, United States
Fangang Meng1